1 day-4.74%
Current month-10.07%
1 month-18.46%
1 week 17,430
Extreme 17430
21,800
1 month 17,430
Extreme 17430
24,400
Current year 9,900
Extreme 9900
29,950
1 year 9,900
Extreme 9900
29,950
3 years 9,900
Extreme 9900
29,950
5 years 9,900
Extreme 9900
29,950
10 years 9,900
Extreme 9900
29,950
Manager TitleAgeSince
Chief Executive Officer 57 22/03/2018
Director TitleAgeSince
Chairman 57 -
Director/Board Member 62 13/04/2026
Change 5-day change 1-year change 3-year change Capi.($)
-4.74%0.00% - - 782M
-2.69%-5.28%+58.42%+65.89% 68.45B
-0.92%+7.70%+12.90%+93.35% 61.31B
0.00%-0.95%+20.09%+99.04% 55.73B
+0.14%+2.35%+13.08%+109.47% 47.51B
-2.21%-2.47%+18.60%+36.89% 44.68B
-2.30%-10.40%+167.61%+776.79% 38.14B
+2.15%-0.47%+22.85%+56.09% 35.85B
-2.32%-5.14%+75.43%+60.15% 33.05B
+2.62%+5.90%-36.55%+406.95% 25.9B
Average -1.03%+2.22%+39.16%+189.40% 41B
Weighted average by Cap. -0.86%+2.25%+39.26%+162.61%

Financials

2024 2025
Net sales 3.53B 2.64M 2.39M 2.21M 2M 3.76M 249M 3.9M 26.59M 10.54M 133M 9.91M 9.7M 422M -
Net income 21.46B 16.05M 14.55M 13.45M 12.14M 22.88M 1.51B 23.68M 162M 64.09M 808M 60.24M 58.96M 2.57B -26.45B -19.79M -17.93M -16.58M -14.96M -28.2M -1.87B -29.19M -199M -78.99M -997M -74.25M -72.67M -3.16B
Net Debt - -
Projected Income Statement - Annual - Ingenia Therapeutics Inc.
Logo Ingenia Therapeutics Inc.
INGENIA Therapeutics Inc is a clinical-stage biotech company. The Company focused on the treatment of damaged capillary-associated indications with clinical needs. The Company is engaged in discovery and development of therapeutic antibody candidates for patient populations suffering from microvascular disorders and progressive chronic diseases. By modifying endothelial cell signaling, the Company provides vascular therapeutics.
Employees
-
Date Price Change Volume
13/11/26 ₩20,100.00 -4.74% 239,099
12/11/26 ₩21,100.00 +1.69% 280,230
11/11/26 ₩20,750.00 +0.48% 161,918
10/11/26 ₩20,650.00 +3.25% 280,701
09/11/26 ₩20,000.00 +12.80% 396,553
  1. Stock Market
  2. Stocks
  3. A950260 Stock